Published in J Invest Dermatol on November 01, 2001
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest (2007) 3.82
Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol (2008) 1.85
Vitamin D metabolism and function in the skin. Mol Cell Endocrinol (2011) 1.40
Autocrine and paracrine actions of vitamin d. Clin Biochem Rev (2010) 1.26
Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep (2015) 1.23
Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem (2014) 1.20
The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients (2010) 1.18
In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Mol Cell Endocrinol (2013) 1.14
Vitamin D: a critical and essential micronutrient for human health. Front Physiol (2014) 1.05
UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol (2014) 1.00
The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol (2012) 0.97
1,25-dihydroxyvitamin D(3) protects human keratinocytes against UV-B-induced damage: In vitro analysis of cell viability/proliferation, DNA-damage and -repair. Dermatoendocrinol (2009) 0.94
The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol (2008) 0.93
Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell Mol Life Sci (2011) 0.89
The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3. Mol Endocrinol (2012) 0.87
Vitamin D and neurocognitive function. Clin Interv Aging (2014) 0.87
Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. Int J Mol Med (2007) 0.85
Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going? Dermatoendocrinol (2011) 0.85
The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr (2014) 0.84
Fundamental questions to sun protection: A continuous education symposium on vitamin D, immune system and sun protection at the University of Zürich. Dermatoendocrinol (2010) 0.83
The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin. Dev Comp Immunol (2009) 0.83
Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells. PLoS One (2015) 0.82
Vitamin d, the cutaneous barrier, antimicrobial peptides and allergies: is there a link? Allergy Asthma Immunol Res (2013) 0.80
Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis. Ther Clin Risk Manag (2015) 0.78
From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer. Dermatoendocrinol (2011) 0.78
Vitamin D and UV exposure in chronic kidney disease. Dermatoendocrinol (2013) 0.78
UV "Indices"-What Do They Indicate? Int J Environ Res Public Health (2016) 0.77
Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters. Curr Drug Metab (2012) 0.77
Novel vitamin D compounds and skin cancer prevention. Dermatoendocrinol (2013) 0.77
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash. Oncotarget (2017) 0.75
Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial. PLoS One (2017) 0.75
Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. Int J Clin Pract (2007) 1.48
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol (1994) 1.23
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med (1996) 1.22
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol (1994) 1.16
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol (2008) 1.14
Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol (1999) 1.14
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology (2009) 1.11
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11
Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol (1988) 1.09
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol (1998) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol (2007) 1.01
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol (2004) 0.99
[Studies on the stabilization of the cornea in rabbits]. Ophthalmologe (2000) 0.96
The emigration of Germany's Jewish dermatologists in the period of National Socialism. J Eur Acad Dermatol Venereol (2003) 0.95
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
[Pachydermoperiostosis]. Hautarzt (1995) 0.93
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res (2003) 0.92
Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol (1996) 0.92
No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol (1995) 0.91
Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents. Exp Dermatol (2000) 0.89
Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study. Arch Dermatol Res (1999) 0.88
Comparison of three methods to detect white blood cells in semen: leukocyte esterase dipstick test, granulocyte elastase enzymeimmunoassay, and peroxidase cytochemistry. Fertil Steril (1992) 0.88
PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol (1996) 0.87
Adherence of Escherichia coli to sperm: a mannose mediated phenomenon leading to agglutination of sperm and E. coli. Fertil Steril (1993) 0.87
Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol (2007) 0.87
[Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil]. Hautarzt (2008) 0.86
Extracellular binding sites of IgA anti-jejunal antibodies on normal small bowel detected by indirect immunoelectronmicroscopy. J Invest Dermatol (1991) 0.86
Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol (1992) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet (1994) 0.86
Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol (1996) 0.85
Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. Int J Dermatol (2000) 0.85
Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas. Effect of contrast medium extravasation. Acta Radiol (2002) 0.84
Male reproductive system in patients exposed to ionizing irradiation in the Chernobyl accident. Arch Androl (1993) 0.84
Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology (1994) 0.84
Psychiatric comorbidity in adult eczema. Br J Dermatol (2009) 0.84
[Pigmented lesions of the genital mucosa]. Hautarzt (2005) 0.83
Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol (2009) 0.83
[Lymphogranuloma venereum. Two cases from Dresden]. Hautarzt (2006) 0.83
Sun exposure: perceptions and behaviours in outdoor workers. Br J Dermatol (2014) 0.83
Impact of clinically silent inflammation on male genital tract organs as reflected by biochemical markers in semen. J Androl (1992) 0.82
Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. Br J Dermatol (1990) 0.82
Antibodies to Ro/SSA detected by ELISA: correlation with clinical features in systemic scleroderma. Br J Dermatol (1989) 0.82
[Toxic epidermal necrolysis induced by NSAID]. Z Rheumatol (2003) 0.82
Herpes gestationis: ultrastructural identification of the extracellular antigenic sites in diseased skin using immunogold techniques. Br J Dermatol (1991) 0.82
Anaesthesia for trigeminal nerve thermocoagulation. Anaesthesia (1983) 0.82
Soluble Il-2 receptor serum levels--a marker for disease progression in patients with HIV-1 infection. Arch Dermatol Res (1989) 0.81
[Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony]. Hautarzt (2009) 0.81
[Histology of cutaneous vasculitides]. Hautarzt (2008) 0.81
Dermatitis herpetiformis bodies. Ultrastructural study on the skin of patients using direct preembedding immunogold labeling. Arch Dermatol (1990) 0.80
Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol (1991) 0.80
Epidermal synthesis and expression of HLA-DR on keratinocytes in lupus erythematosus. Arch Dermatol Res (1985) 0.80
Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis (1998) 0.80
Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol (1996) 0.80
Mycophenolate mofetil for dermatomyositis. Dermatology (2001) 0.80
Levels of type IV collagen and laminin fragments in serum from patients with progressive systemic sclerosis. J Rheumatol (1988) 0.80
Orificial tuberculosis: detection by polymerase chain reaction. Br J Dermatol (1996) 0.80
A novel pathway for hormonally active calcitriol. Horm Res (2000) 0.80
Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome. Toxicol Appl Pharmacol (1998) 0.80
Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol (1985) 0.80
Is the atypical neutrophilic dermatosis with subcorneal IgA deposits a variant of pemphigus foliaceus. Br J Dermatol (1989) 0.79
Detection of Chlamydia trachomatis in semen by antibody-enzyme immunoassay compared with polymerase chain reaction, antigen-enzyme immunoassay, and urethral cell culture. Fertil Steril (1994) 0.79
Small animal positron emission tomography in food sciences. Amino Acids (2005) 0.79
[Atopic exzema in adulthood]. Hautarzt (2008) 0.79
UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in the human keratinocyte line HaCaT. Photochem Photobiol (2000) 0.79
Chlamydia trachomatis induces an inflammatory response in the male genital tract and is associated with altered semen quality. Fertil Steril (1991) 0.79
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol (2005) 0.79
Human keratinocyte line HaCaT metabolizes 1alpha-hydroxyvitamin D3 and vitamin D3 to 1alpha,25-dihydroxyvitamin D3 (calcitriol). J Dermatol Sci (1998) 0.79
Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP. Int J Artif Organs (2002) 0.78
Comparative in vitro susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy (1986) 0.78
Biodistribution and catabolism of 18F-labelled isopeptide N(epsilon)-(gamma-glutamyl)-L-lysine. Amino Acids (2005) 0.78
Acute mercury intoxication with lichenoid drug eruption followed by mercury contact allergy and development of antinuclear antibodies. Acta Derm Venereol (1992) 0.78
High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. Br J Dermatol (1995) 0.78
Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells. Mol Cell Endocrinol (2012) 0.78
[Gout tophi and Heberden nodules in hyperuricemia]. Hautarzt (1994) 0.78
Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol (1979) 0.78
Juvenile pemphigus foliaceus associated with severe nonscarring alopecia. Br J Dermatol (2009) 0.78
Blood rheology in lupus erythematosus. Ann Rheum Dis (1991) 0.77
Clinical association of autoantibodies to fibrillarin with diffuse scleroderma and disseminated telangiectasia. J Am Acad Dermatol (1990) 0.77
[Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)]. Z Rheumatol (2008) 0.77
[In memory of our Jewish colleagues who were murdered or committed suicide during the National Socialist Era]. Hautarzt (2007) 0.77
[Seborrheic dermatitis]. Hautarzt (2011) 0.77
Cutaneous malignant fibrous histiocytoma of the scalp in a renal transplant recipient. Br J Dermatol (2006) 0.77